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INTRODUCTION

RESULTS

RESULTS

• Lung cancer (LC) is the most commonly diagnosed cancer
worldwide and the most frequent cause of cancer death in both men
and women in the US (more deaths than the next three most
common cancers combined)1

• Of the 189 mediastinal or hilar lymph node specimens, only 14
were deemed insufficient (93% adequate) (table 1)
• Of the 175 adequate specimen, 46% were malignant (metastatic
neoplasm), 35% were benign, and 5% were atypical/suspicious

• Table 2: Subtyping results of malignant and lymphoma
specimens

• Clinical staging of LC is an integral part of patient care because it
directs therapy and has prognostic value
• Patients are routinely investigated with a conventional workup
(medical history, PE, lab tests, bronchoscopy), CT and
integrated whole-body PET-CT, followed by mediastinal tissue
staging for enlarged or PET-positive intrathoracic nodes2
• Mediastinal tissue staging has been classically performed by
mediastinoscopy, but they can also be sampled under real-time
ultrasound control from the airways (endobronchial ultra-sound
guided fine needle aspiration [EBUS-FNA]).
• Current lung cancer staging guidelines acknowledge
endosonography as a minimally invasive alternative to surgical
staging to detect nodal disease,3,4 reducing the need for
surgical staging in up to two thirds of patients5,6

# of Specimen

%

Lung Adenocarcinoma

29

36%

Lung Squamous cell carcinoma

15

19%

. 

Lung small cell carcinoma

10

12%

31

Large cell neuroendocrine

2

2%

##( %

4

Other than lung primary

19

23%

%

2

Lymphoma

6

7%

Table 1:Diagnosis from EBUS-FNA Specimen
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• The purpose of this study was to evaluate the diagnostic yield
of EBUS-FNA for accurate lung cancer staging, subtyping and
assessment of mediastinal lymphadenopathy

METHODS
• Retrospective evaluation of 189 mediastinal or hilar lymph node
specimens from 99 patients, obtained by EBUS-FNA in the last two
years at Thomas Jefferson University Hospital

Subtypes

• Cell blocks prepared for 179 specimen and of those, 5 did not
survive and/or were nondiagnostic (97% sufficient)
• Of the 75 malignant diagnosis, immunohistochemistry was
performed on 40 cellblock preparations, 18 were performed on
another part on the same patient, 1 was performed but was
insufficient, and 16 were not performed

CONCLUSION

Fig.1 Metastatic squamous cell carcinoma. Group of malignant cells with
irregular nuclei with coarsely clumped chromatin in a background of benign
lymphocytes. Single cell with eosinophilic keratinization and hyperchromatic
nucleus. Papanicolaou stain; x40.

• Endobronchial ultrasound-guided fine needle aspiration (EBUSFNA) in lung cancer staging, subtyping and diagnosis of
unexplained mediastinal lymphadenopathy provides a good
diagnostic yield
• This study supports endosonography as a minimally invasive
alternative to surgical staging

• Adequacy defined by the presence of malignant cells,
granulomatous lymphadenitis or sufficient number of lymphocytes
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